|
Menzi, P., Bernhardt Keller, A., Monterrubio Leu, C., & Galgano, M. L. (2010). Hepatitis C : manual prevention and therapy. Berne: Infodrog.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
Kickbusch, I., van der Linde, F., Zapfl, R., Meili, B., Abelin, T., Chinet, L., et al. (2010). The challenge of addiction : foundations for a future oriented policy on addiction in Switzerland (for D. I. and for T. C. Steering Group of the three Federal Commissions for alcohol Issues, Ed.). Berne: Steering Group Challenge of Addiction.
Abstract: The Report on the Challenge of Addiction is intended as a contribution towards an integrated understanding of addiction policy on the basis of a public health approach. From a health policy perspective, the Report proposes broadening the scope of addiction policy in Switzerland and changing its strategic focus and direction. It recommends ten principles. These are intended to contribute to a coherent policy response to the problematic consumption of all psychoactive substances and to behaviours with addictive potential.
Keywords: government and politics; public health; AOD public policy strategy; addiction; AOD dependence; drug legalization; Switzerland
|
|
|
Burkhart, G. (2010). Prevention and evaluation resources kit (PERK) : a manual for prevention professionals (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This manual compiles basic but evidence-based prevention principles, planning rules and evaluation tips. Additionally, it provides related documentation or references for download; it is hoped that this additional material will be particularly useful for readers who have difficulty accessing the scientific prevention literature. To illustrate the theoretical discussion, an intervention example, partly based on a real-life situation, gives a practical perspective.
Keywords: prevention; assessment; program planning, implementation, and evaluation; program planning; program implementation; program evaluation; prevention outcome; training manual
|
|
|
Bundesamt für Gesundheit. (2008). Nationales Programm Alkohol 2008-2012. Bern: Bundesamt für Gesundheit (BAG).
Keywords: government and politics; alcohol; Switzerland
|
|
|
Office fédéral de la santé publique. (2008). Programme national alcool 2008-2012. Berne: Office fédéral de la santé publique (OFSP).
Keywords: government and politics; alcohol; Switzerland
|
|
|
Ufficio federale della sanità pubblica. (2008). Programma nazionale alcol 2008-2012. Berna: Ufficio federale della sanità pubblica (UFSP).
Keywords: government and politics; alcohol; Switzerland
|
|
|
various. (2010). Guidelines for collecting data on retail drug prices in Europe : issues and challenges (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 5. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the workings of drug supply mechanisms. They may also be used to help target law enforcement resources and assist criminal justice agencies with decisions related to prosecution and sentencing (e.g. assets recovery). The EMCDDA has been collecting information on retail drug prices via its Reitox focal points for the last 15 years. Although considerable progress has been made in this area, there is still variation in data collection in Europe. To address this issue, the EMCDDA has released these Guidelines for collecting data on retail drug prices in Europe: issues and challenges in its Manuals series. The Manual raises awareness on specific issues related to collecting data on retail drug prices and offers practical suggestions. It addresses difficulties in obtaining a definition of ’retail’ prices, and discusses the challenge of obtaining a representative sample of illicit, and therefore hidden, transactions. Suggestions are made for a minimum set of variables to be recorded for each observation. Targeted at all those involved in data collection on drug prices in Europe, the Manual reviews the main data-collection methods, current national practices and data-management issues.
Keywords: research; data collection; price and pricing; illicit drug; recommendations or guidelines; Europe
|
|
|
various. (2007). Guidelines for the evaluation of treatment in the field of problem drug use : a manual for researchers and professionals (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 3. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The main objective of the guidelines is to provide a European audience with basic information on the options, elements and procedures of drug-related treatment evaluation. The target readership includes professionals working in treatment services for substance use and dependence, administrators and officials in social and health authorities, researchers dealing with treatment of substance dependence, and those who professionally or politically may have an interest in evidence from treatment evaluation.
Keywords: research; government and politics; treatment and maintenance; addiction; AOD dependence; chemical addiction; diagnosis; recommendations or guidelines; Europe
|
|
|
various. (2010). Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 6. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying conditions such as poor hygiene, homelessness and poverty. There is a recognised need for guidance on providing IDUs with a medical examination and testing for HIV, viral hepatitis and several other infections on a regular basis. In addition, improving testing uptake in this group would benefit epidemiological surveillance and monitoring as carried out at the national and international level. These guidelines are accompanied by a recommended package of prevention and primary care in relation to injecting drug users and infections. Treatment and other specialist care are not discussed in detail but are dealt with by indicating referral to appropriate services.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; health; prevention; primary health care; communicable disease; intravenous drug user; risk-taking behavior; viral hepatitis; HIV infection; social services; recommendations or guidelines; Europe
|
|
|
European Monitoring Centre for Drugs and Drug Addiction, & Inter-American Drug Abuse Control Commission of the Organization of American States. (2010). Building a national drugs observatory : a joint handbook. Joint publications. Luxembourg: Office for Official Publications of the European Communities.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
|